Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2013-07-19

Guideline on medicines for the treatment of irritable bowel syndrome released for a six-month public consultation

View source ↗

Summary

EMA released a guideline on medicines for the treatment of irritable bowel syndrome for a six-month public consultation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications